Literature DB >> 4031854

Characterization of human brain S100 protein fraction: amino acid sequence of S100 beta.

R Jensen, D R Marshak, C Anderson, T J Lukas, D M Watterson.   

Abstract

Two major components of human brain S100 fraction were purified by HPLC and an amino acid sequence was elucidated for the S100 beta component. Human S100 proteins showed absorption spectra and amino acid compositions similar to S100 alpha and S100 beta from bovine brain. However, the relative amounts of the human proteins were 4% S100 alpha and 96% S100 beta by weight, while the bovine protein distribution was 47% S100 alpha and 53% S100 beta by weight. An amino acid sequence of human S100 beta was established by analysis of overlapping fragments generated by cyanogen bromide and trypsin cleavage. Three amino acid sequence differences between the human and bovine S100 beta were found at residues 7, 62, and 80. These differences were chemically conservative and compatible with minimum single base changes in the codon structures. These results document that S100 beta is a conserved protein among mammals and provide the necessary foundation for current clinical studies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031854     DOI: 10.1111/j.1471-4159.1985.tb04048.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Evolution of EF-hand calcium-modulated proteins. I. Relationships based on amino acid sequences.

Authors:  N D Moncrief; R H Kretsinger; M Goodman
Journal:  J Mol Evol       Date:  1990-06       Impact factor: 2.395

2.  S100B protein may detect brain death development after severe traumatic brain injury.

Authors:  Juan J Egea-Guerrero; Francisco Murillo-Cabezas; Elena Gordillo-Escobar; Ana Rodríguez-Rodríguez; Judy Enamorado-Enamorado; Jaume Revuelto-Rey; María Pacheco-Sánchez; Antonio León-Justel; Jose M Domínguez-Roldán; Angel Vilches-Arenas
Journal:  J Neurotrauma       Date:  2013-08-28       Impact factor: 5.269

3.  Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study.

Authors:  M Otto; J Wiltfang; E Schütz; I Zerr; A Otto; A Pfahlberg; O Gefeller; M Uhr; A Giese; T Weber; H A Kretzschmar; S Poser
Journal:  BMJ       Date:  1998-02-21

4.  Isolation, characterization and metal-ion-binding properties of the alpha-subunit from S-100a protein.

Authors:  I K Leung; R S Mani; C M Kay
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

5.  Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation.

Authors:  E Lagasse; R G Clerc
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

6.  Purification and characterization of a neurite extension factor from bovine brain.

Authors:  D Kligman; D R Marshak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation.

Authors:  A Kruse; K G Cesarini; F W Bach; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

8.  Profilaggrin is a major epidermal calcium-binding protein.

Authors:  N G Markova; L N Marekov; C C Chipev; S Q Gan; W W Idler; P M Steinert
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

9.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death.

Authors:  Diego Gazzolo; Alessandro Frigiola; Moataza Bashir; Iman Iskander; Hala Mufeed; Hanna Aboulgar; Pierluigi Venturini; Mauro Marras; Giovanni Serra; Rosanna Frulio; Fabrizio Michetti; Felice Petraglia; Raul Abella; Pasquale Florio
Journal:  PLoS One       Date:  2009-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.